Corpus luteum follicle-stimulating hormone (FSH). A new corpus luteum develops with each menstrual cycle. The "corpus luteum" develops from an ovarian follicle during the luteal phase of the menstrual cycle or oestrous cycle, following the release of a secondary oocyte from the follicle during ovulation. The follicle first forms a corpus hemorrhagicum before it becomes a corpus luteum, but the term refers to the visible collection of blood, left after rupture of the follicle, that secretes progesterone. While the oocyte (later the zygote if fertilization occurs) traverses the Fallopian tube into the uterus, the corpus luteum remains in the ovary. The corpus
Pharmacokinetics of progesterone and has been found to result in higher serum peak progesterone levels relative to intramuscular oil formulations. In addition, subcutaneous injection of progesterone is considered to be easier, safer (less risk of injection site reactions), and less painful relative to intramuscular injection. The elimination half-life of this formulation is 13 to 18 hours, compared to 20 to 28 hours for intramuscular injection in oil. Progesterone has a very short elimination half-life of about 3 to 90 minutes when given by intravenous injection. A one-year progesterone intrauterine device (IUD) for hormonal birth control was previously available in the United States and